Agoracom Blog

AGORACOM Welcomes Supreme Pharmaceuticals (SL: CSE) Canada’s Newest Entrant to $1.3B Medical Marijuana Industry

Posted by AGORACOM-JC at 10:53 AM on Monday, August 25th, 2014


Supreme Pharmaceuticals Inc. dedicated to securing multiple producing medical marijuana facilities in Canada and applying for several MMPR commercial production licences.

South Okanagan Producing Facility

About The Facility

The Vendor currently owns its own facility in Okanagan Falls, British Columbia. The Vendor has cost effectively facilitated Personal-use Production License holders production of monthly crops of approximately 16,000 grams/month of medical marihuana in full compliance with all regulatory authorities. In the application for the MMPR, the company has applied for a significantly larger amount for commercial production.

The medical marijuana currently produced by private license holders requires a strictly controlled and augmented growing environment to consistently reach optimal plant characteristics in 90 days. The Vendor has designed and constructed 3 indoor purpose specific greenhouses, each of which are planted monthly, and harvested at 90 days.

Each greenhouse is fully climate controlled, with all key growing elements monitored and computer controlled to ensure consistent production. There are production elements, which require brief manual monitoring and intervention on a daily basis, but all key environmental functions are electronically controlled. The details of the process are highly commercially sensitive and valuable, and will not be disclosed until a full sale transaction is concluded.

The facility has been built to be fully compliant with all relevant building and safety requirements. All electrical, plumbing, security, and related plant and equipment are built to full commercial standards.

The facility has received and replied to the Department of Health Canada on its Marihuana for Medical Purposes Regulations Licence (MMPR) application, who required additional information on:

  • External and internal security measures
  • Updated site survey and aerial photographs
  • Further information on principal and proposed technical employees
  • Details on record keeping and information handling procedures

The Vendor has engaged external consultants and specialists to assist in the application process who have been able to respond and provide the requested documentation in a timely manner. While the Vendor is confident that their prior experience and expertise in the industry and the high commercial standards of the production facility will enable full compliance with Department of Health requirements for a full commercial MMPR license, there is no guarantee a MMPR license will be granted.

Management of Supreme and its operating subsidiary recently met with government officials, including the fire chief, local politicians, and community stakeholders in the township where its Southern Ontario green house facility (Facility 2) is located. The Company does not foresee any concerns in this area as construction progresses such that it may eventually receive final receipt of the MMPR license.

Gupta: ‘I am doubling down’ on medical marijuana

Dr. Sanjay Gupta, CNN Cheif Medical Correspondent. We have no affiliation with this well known medical expert, but his latest “Doubling Down” on the medical marijuana sector is worthy of your attention. Reasons such as these convince us we are doing the right thing in entering this market.

Medical marijuana and ‘the entourage effect’

12 Month Stock Chart

Tags: , , ,

Comments are closed.